Dignify Therapeutics’ Chief Scientific Officer invited to participate at CURE-UAB
Dignify Therapeutics’ Chief Scientific Officer, Karl B. Thor, PhD, has been invited to participate as a Faculty member at the 2nd International Congress on Underactive Bladder – CURE-UAB in Denver, CO, Dec. 3-4, 2015. His presentation is entitled “Pharmaceutical Targets for Drug-induced Voiding”. This NIH-sponsored congress brings together academic, pharmaceutical, and medical device experts to…

